A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics

Journal of Vascular Surgery

Volumn 54, Issue 5, 2011, Pages 1332-1338

  Dorigo, Walter ^a   Pulli, Raffaele ^a   Castelli, Patrizio ^b   Dorrucci, Vittorio ^c   Ferilli, Fiore ^d   De Blasis, Giovanni ^e   Monaca, Vincenzo ^f   Vecchiati, Enrico ^g   Pratesi, Carlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Umberto I Hospital   (Italy)

^d S MARIA HOSPITAL   (Italy)

^e SS Filippo e Nicola Hospital   (Italy)

^f VE Ferrarotto S Bambino Hospital   (Italy)

^g Hospital S Maria Nuova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; POLITEF;

ACUTE HEART INFARCTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; BELOW KNEE AMPUTATION; BLEEDING; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE REGISTRY; FEMALE; FOLLOW UP; GRAFT OCCLUSION; GRAFT PATENCY; GRAFT SURVIVAL; HUMAN; ITALY; LEG REVASCULARIZATION; LENGTH OF STAY; LIMB ISCHEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; SECOND LOOK SURGERY; SURVIVAL RATE;

AGED; AMPUTATION; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CRITICAL ILLNESS; DIABETIC ANGIOPATHIES; FEMALE; GRAFT OCCLUSION, VASCULAR; HEPARIN; HOSPITAL MORTALITY; HUMANS; ISCHEMIA; ITALY; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; ODDS RATIO; PATIENT SELECTION; POLYTETRAFLUOROETHYLENE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 81155162546     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.05.046     Document Type: Article

References (17)

1. Hertzer NR, Bena JF, Karafa MT. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 2007;46:271-79.
2. Goodney PP, Nolan BW, Schanzer A, Eldrup-Jorgensen J, Bertges DJ, Stanley AC, et al. Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg 2010;24:57-68.
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
4. Conte MS. Challenges of distal bypass surgery in patients with diabetes: Patient selection, techniques, and outcomes. J Vasc Surg 2010;52:96S-103S.
5. Pulli R, Dorigo W, Castelli P, Dorrucci V, Ferilli F, De Blasis G, et al. Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg 2010;51:1167-77.
6. Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology 1991;181:277-81.
7. Taylor LM, Jr, Edwards JM, Brant B, Phinney ES, Porter JM. Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein. Am J Surg 1987;153:505-10. (Pubitemid 17102222)
8. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery, in Vasc-Surg J (ed); 2006;43:742-51; discussion: 751.
9. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoralpopliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-77. (Pubitemid 30644940)
10. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003;37:1263-9. (Pubitemid 41123104)
11. Ritter EF, Kim YB, Reischl HP, Serafin D, Rudner AM, Klitzman B. Heparin coating of vascular prostheses reduces thromboemboli. Surgery 1997;122:888-92. (Pubitemid 27495929)
12. Clowes AW. Intimal hyperplasia and graft failure. Cardiovasc Pathol 1993;2:179-86.
13. Begovac PC, Thomson RC, Fisher JL, Hughson A, Gällhagen A. Improvements in Gore-Tex vascular graft performance by Carmeda bioactive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003;25:432-37. (Pubitemid 36603293)
14. Battaglia G, Tringale R, Monaca V. Retrospective comparison of a heparin bonded ePTFE graft and saphenous vein for infragenicular bypass: implications for standard treatment protocol. J Cardiovasc Surg 2006;47:41-7.
15. Dorrucci V, Griselli F, Petralia G, Spinamano L, Adornetto R. Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg 2008;49:145-9. (Pubitemid 351833233)
16. Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J Vasc Surg 2009;49:1210-16.
17. Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, et al. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg 2009;50:769-75; Discussion: 775.